BREAKING NEWS

An F.D.A. analysis questioned the strength of the evidence Johnson & Johnson provided for booster shots.

Wednesday, October 13, 2021 11:49 AM EST

A key test used by the company was likely not sensitive enough, the agency suggested, adding that it didn't have enough time to independently review much of the raw data from the trials.

Read the latest